Discover how Evelo’s EDP1815 may prevent the progression of COVID-19. Learn More

skip to content

Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team

Cambridge, Mass. - July 11, 2017

Read the original article here